Benzinga's Volume Movers

surged 3.19% to $18.63. The volume of Inphi shares traded 282% higher than normal. Inphi's PEG ratio is 1.81.

shares climbed 16.83% to $16.24. The volume of Tekmira Pharmaceuticals shares traded was 239% higher than normal. Tekmira shares jumped following update on TKM-PLK1 Phase I/II clinical study.

shares rose 7.14% to $24.61. The volume of Cempra shares traded was 99% higher than normal. Stifel Nicolaus maintained Cempra with a Buy and raised the price target from $22.00 to $33.00.

shares moved up 5.31% to $16.26. The volume of Osiris Therapeutics traded was 90% higher than normal. Osiris Therapeutics shares have dropped 3.38% over the past 52 weeks, while the S&P 500 index has surged 13.56% in the same period.